Neuroendocrine Carcinoma: Surgery of Peritoneal Metastasis

#707

Introduction: Neuroendocrine tumor (NET)-derived peritoneal metastases (PM) are not really described nor taken into account in the literature, yet they exert an impact on overall survival (OS)

Aim(s): To report the results of systematic cytoreductive surgery of NET-derived PM and to compare patients treated with or without adding hyperthermic intraperitoneal chemotherapy (HIPEC).

Materials and methods: From 1994 to 2012, 41 patients underwent complete cytoreductive surgery (CCRS) with HIPEC (n=28) from 1994 to 2007, then without HIPEC (n=13) from 2008 to 2012. Liver metastases (LM) were treated during the same surgical procedure in 66% of the patients.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Dumont F

Authors: Elias D, David A, Sourouille I, Honoré C, Goéré D,

Keywords: neuroendocrine tumor, peritoneal metastases, hyperthermic intraperitoneal chemotherapy,